{
  "id": "56f1547c2ac5ed1459000010",
  "type": "yesno",
  "question": "Has single guide RNA been used on human cells?",
  "ideal_answer": "Yes, sgRNA has been used in human cell lines.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24336569",
    "http://www.ncbi.nlm.nih.gov/pubmed/23873081",
    "http://www.ncbi.nlm.nih.gov/pubmed/25122746",
    "http://www.ncbi.nlm.nih.gov/pubmed/24870050",
    "http://www.ncbi.nlm.nih.gov/pubmed/25048165",
    "http://www.ncbi.nlm.nih.gov/pubmed/25759096",
    "http://www.ncbi.nlm.nih.gov/pubmed/24136345",
    "http://www.ncbi.nlm.nih.gov/pubmed/24770324",
    "http://www.ncbi.nlm.nih.gov/pubmed/23907171",
    "http://www.ncbi.nlm.nih.gov/pubmed/23940360",
    "http://www.ncbi.nlm.nih.gov/pubmed/23999092"
  ],
  "snippets": [
    {
      "text": "We used a library containing 73,000 sgRNAs to generate knockout collections and performed screens in two human cell lines.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336569",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we engineer this system to enable RNA-guided genome regulation in human cells by tethering transcriptional activation domains either directly to a nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907171",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The type II CRISPR/Cas system from Streptococcus pyogenes and its simplified derivative, the Cas9/single guide RNA (sgRNA) system, have emerged as potent new tools for targeted gene knockout in bacteria, yeast, fruit fly, zebrafish and human cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23999092",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we engineer this system to enable RNA-guided genome regulation in human cells by tethering transcriptional activation domains either directly to a nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907171",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using synthetic single RNA guides, Cas9 can be reprogrammed to create specific double-stranded DNA breaks in the genomes of a variety of organisms, ranging from human cells to bacteria, and thus constitutes a powerful tool for genetic engineering. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25048165",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we engineer this system to enable RNA-guided genome regulation in human cells by tethering transcriptional activation domains either directly to a nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23907171",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017394"
  ],
  "exact_answer": "Yes"
}